REFERENCES
- Aghajanian, G. & Marek, G. 1999. Serotonin and hallucinogens. Neuropsychopharmacology 21 (suppl 2): 16S–23S.
- Brandup, E. & Vanggaard, T. 1977. LSD treatment in a severe case of compulsive neurosis. Acta Psychiatrica Scandinavica 55: 127–141.
- Delgado, P. & Moreno, F. 1998. Hallucinogens, serotonin, and obsessive compulsive disorder. Journal of Psychoactive Drugs 30: 359–366.
- Fineberg, N.; Brown, A.; Reghunandanan, S. & Pampaloni, I. 2012. Evidence-based pharmacotherapy of obsessive-compulsive disorder. International Journal of Neuropsychopharmacology 15(8): 1173–91.
- Goodman, W.; Price, L. & Delgado, P. 1990. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry 47: 577–585.
- Hoffer, A. & Osmond, H. 1967. The Hallucinogens. New York: Academic Press, 480–510.
- Karno, M.; Golding, J. & Sorenson, S. 1988. The epidemiology of obsessive compulsive disorder in 5 US communities. Archives of General Psychiatry 45: 1094–1099.
- Kessler, R.; McGonagle, K. & Zhao, S. 1994. Lifetime and 12 month prevalence of DSMIII-R psychiatric disorders in the United States. Archives of General Psychiatry 51: 8–19.
- Moreno, F.; Wieland, C.; Taitono, E. & Delgado, P. 2006. Safety, tolerability, and efficacy of psilocybin in 9 patients with Obsessive-Compulsive Disorder. Journal of Clinical Psychiatry 67 (11): 1735–1741.
- Patel, S.; Aronson, J.; Sheth, S. & Eskandar, E. 2013. Lesion procedures in psychiatric neurosurgery. World Neurosurgery 80 (3–4): S31 e9–16.
- Ramesh, V. & Balasubraminian, C. 2013. Obsessive-compulsive disorder and cingulotomy. Journal of Neurosurgery 119(2): 526.
- van Vliet, I.; van Well, E.; Bruggeman, R.; Campo, J.; Hijman, R.; van Megen, H.; van Balkom, A. & van Rijen, P. 2013. An evaluation of irreversible psychosurgical treatment of patients with obsessive-compulsive disorder in the Netherlands, 2001-2008. Journal of Nervous and Mental Disease 201 (3): 226–8.